{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:05:59Z","timestamp":1790622359711,"version":"4.1.0"},"reference-count":33,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T00:00:00Z","timestamp":1451520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Urinary tract infection (UTI) is the second most common infection in humans after those involving the respiratory tract. This results not only in huge annual economic costs, but in decreased workforce productivity and high patient morbidity. Most infections are caused by uropathogenic Escherichia coli (UPEC). Antibiotic treatment is generally effective for eradication of the infecting strain; however, documentation of increasing antibiotic resistance, allergic reaction to certain pharmaceuticals, alteration of normal gut flora, and failure to prevent recurrent infections represent significant barriers to treatment. As a result, approaches to prevent UTI such as vaccination represent a gap that must be addressed. Our laboratory has made progress toward development of a preventive vaccine against UPEC. The long-term research goal is to prevent UTIs in women with recurrent UTIs. Our objective has been to identify the optimal combination of protective antigens for inclusion in an effective UTI vaccine, optimal adjuvant, optimal dose, and optimal route of delivery. We hypothesized that a multi-subunit vaccine elicits antibody that protects against experimental challenge with UPEC strains. We have systematically identified four antigens that can individually protect experimentally infected mice from colonization of the bladder and\/or kidneys by UPEC when administered intranasally with cholera toxin (CT) as an adjuvant. To advance the vaccine for utility in humans, we will group the individual antigens, all associated with iron acquisition (IreA, Hma, IutA, FyuA), into an effective combination to establish a multi-subunit vaccine. We demonstrated for all four vaccine antigens that antigen-specific serum IgG represents a strong correlate of protection in vaccinated mice. High antibody titers correlate with low colony forming units (CFUs) of UPEC following transurethral challenge of vaccinated mice. However, the contribution of cell-mediated immunity cannot be ruled out and must be investigated experimentally. We have demonstrated that antibodies bind to the surface of UPEC expressing the antigens. Sera from women with and without histories of UTI have been tested for antibody levels to vaccine antigens. Our results validate iron acquisition as a target for vaccination against UTI.<\/jats:p>","DOI":"10.3390\/pathogens5010001","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T02:29:07Z","timestamp":1451960947000},"page":"1","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Development of a Vaccine against Escherichia coli Urinary Tract Infections"],"prefix":"10.3390","volume":"5","author":[{"given":"Harry","family":"Mobley","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Alteri","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,12,31]]},"reference":[{"key":"ref_1","unstructured":"Schappert, S.M., and Rechtsteiner, E.A. Ambulatory medical care utilization estimates for 2006. Available online: http:\/\/198.246.124.22\/nchs\/data\/nhsr\/nhsr008.pdf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2105\/AJPH.80.3.331","article-title":"Recurring urinary tract infection: Incidence and risk factors","volume":"80","author":"Foxman","year":"1990","journal-title":"Am. J. Public Health"},{"key":"ref_3","unstructured":"Mobley, H.L.T., and Warren, J.W. (1996). Urinary Tract Infections: Molecular Pathogenesis and Clinical Management, ASM Press."},{"key":"ref_4","unstructured":"Litwin, M.S., and Saigal, C.S. (2007). Introduction."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrurol.2010.190","article-title":"The epidemiology of urinary tract infection","volume":"7","author":"Foxman","year":"2010","journal-title":"Nat. Rev. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/01.ju.0000152365.43125.3b","article-title":"Urologic diseases in America Project: Analytical methods and principal findings","volume":"173","author":"Litwin","year":"2005","journal-title":"J. Urol."},{"key":"ref_7","unstructured":"Kunin, C.M. (1987). Detection, Prevention and Management of Urinary Tract Infections, Lea & Febiger. [4th ed.]."},{"key":"ref_8","unstructured":"DeFrances, C.J., Lucas, C.A., Buie, V.C., and Golosinskiy, A. 2006 National Hospital Discharge Survey. Available online: http:\/\/198.246.124.22\/nchs\/data\/nhsr\/nhsr005.pdf."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/0003-4819-135-1-200107030-00012","article-title":"Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections","volume":"135","author":"Gupta","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/j.1365-2672.2008.04115.x","article-title":"Antibiotherapy and pathogenesis of uncomplicated UTI: Difficult relationships","volume":"106","author":"Moura","year":"2009","journal-title":"J. Appl. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijantimicag.2005.08.003","article-title":"Antibiotic resistance in outpatient urinary isolates: Final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)","volume":"26","author":"Zhanel","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1128\/AAC.00123-06","article-title":"Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: Results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study","volume":"50","author":"Karlowsky","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1128\/IAI.00069-08","article-title":"Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder","volume":"76","author":"Billips","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.4049\/jimmunol.0902386","article-title":"The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection","volume":"184","author":"Sivick","year":"2010","journal-title":"J. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Alteri, C.J., Hagan, E.C., Sivick, K.E., Smith, S.N., and Mobley, H.L. (2009). Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog, 5.","DOI":"10.1371\/journal.ppat.1000586"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00296534","article-title":"Protection by a polyvalent vaccine against challenge infection and pyelonephritis","volume":"20","author":"Kruze","year":"1992","journal-title":"Urol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00510527","article-title":"Urinary antibody response after immunisation with a vaccine against urinary tract infection","volume":"17","author":"Kruze","year":"1989","journal-title":"Urol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.4049\/jimmunol.176.5.3080","article-title":"Antigen-specific responses accelerate bacterial clearance in the bladder","volume":"176","author":"Thumbikat","year":"2006","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0022-5347(17)37756-X","article-title":"Immunization against urinary tract infection with a multi-valent vaginal vaccine","volume":"146","author":"Uehling","year":"1991","journal-title":"J. Urol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/315258","article-title":"Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli","volume":"181","author":"Langermann","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/erv.12.36","article-title":"Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine","volume":"11","author":"Brumbaugh","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0924-8579(02)00106-1","article-title":"Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: A meta-analysis of five placebo-controlled double-blind studies","volume":"19","author":"Bauer","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1128\/IAI.00076-06","article-title":"Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine","volume":"75","author":"Alteri","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2958.2008.06509.x","article-title":"Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection","volume":"71","author":"Hagan","year":"2009","journal-title":"Mol. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1128\/IAI.72.11.6373-6381.2004","article-title":"Transcriptome of uropathogenic Escherichia coli during urinary tract infection","volume":"72","author":"Snyder","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Hagan, E.C., Lloyd, A.L., Rasko, D.A., Faerber, G.J., and Mobley, H.L. (2010). Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog, 6.","DOI":"10.1371\/journal.ppat.1001187"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"18327","DOI":"10.1073\/pnas.1415959112","article-title":"Host-specific induction of Escherichia coli fitness genes during human urinary tract infection","volume":"111","author":"Subashchandrabose","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1128\/IAI.00752-12","article-title":"Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract","volume":"80","author":"Spurbeck","year":"2012","journal-title":"Infect. Immun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1128\/IAI.00337-07","article-title":"Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection","volume":"75","author":"Hagan","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mimet.2009.04.013","article-title":"Identification of uropathogenic Escherichia coli surface proteins by shotgun proteomics","volume":"78","author":"Walters","year":"2009","journal-title":"J. Microbiol. Methods"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1128\/JB.01744-06","article-title":"Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli","volume":"189","author":"Lloyd","year":"2007","journal-title":"J. Bacteriol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"17020","DOI":"10.1073\/pnas.252529799","article-title":"Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli","volume":"99","author":"Welch","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1128\/IAI.00470-13","article-title":"Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection","volume":"81","author":"Brumbaugh","year":"2013","journal-title":"Infect. Immun."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/5\/1\/1\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:55:07Z","timestamp":1760216107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/5\/1\/1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,31]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,3]]}},"alternative-id":["pathogens5010001"],"URL":"https:\/\/doi.org\/10.3390\/pathogens5010001","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,31]]}}}